|Original language||English (US)|
|Number of pages||2|
|State||Published - Aug 24 2010|
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Lifestyles of the young and migrainous. / Hershey, Andrew D.; Lipton, Richard B.In: Neurology, Vol. 75, No. 8, 24.08.2010, p. 680-681.
Research output: Contribution to journal › Editorial › peer-review
TY - JOUR
T1 - Lifestyles of the young and migrainous
AU - Hershey, Andrew D.
AU - Lipton, Richard B.
N1 - Funding Information: Prof. Hershey has served/serves on scientific advisory boards for Boehringer Ingelheim, MAP Pharmaceuticals, Inc., GlaxoSmithKline, and Merck Serono; serves as Associate Editor for Headache and Cephalagia; and receives research support from GlaxoSmithKline, Endo Pharmaceutical, and the NIH (RO1 NS 045752-01 [PI], R01-NS050536-01A1 [Co-PI], and R01 NS046641 [Site Co-I]) . Dr. Lipton serves/has served on scientific advisory boards for and received funding for travel from Bayer Schering Pharma, Merck Serono, GlaxoSmithKline, Endo Pharmaceuticals, Kowa Pharmaceuticals America, Inc., Allergan, Inc., Neuralieve Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.; has received funding for travel from the American Headache Society and the Diamond Headache Center; serves as Associate Editor of Cephalalgia and on the editorial boards of Neurology® and Headache; receives royalties from publishing Headache in Clinical Practice (Isis Medical Media, 2002), Headache in Primary Care (Isis Medical Media, 1999), Wolff's Headache (Oxford University Press, 2001, 2008), Managing Migraine: A Physician's Guide (BC Decker, 2008), and Managing Migraine: A Patient's Guide (BC Decker, 2008); has received speaker honoraria from the National Headache Foundation, the University of Oklahoma, the American Academy of Neurology, the Annenberg Foundation, Merck Serono, GlaxoSmithKline, and Coherex Medical; receives research support from the American Headache Society, National Headache Foundation, the Migraine Research Foundation, and the NIH (PO1AG03949 [Program Director, Project Leader], PO1AG027734 [Project Leader], RO1AG25119 [Co-I], K23AG030857 [Co-Mentor], K23NS05140901A1 [Co-Mentor], and K23NS47256 [Mentor] ; and holds stock options in Minster Pharmaceuticals plc.
PY - 2010/8/24
Y1 - 2010/8/24
UR - http://www.scopus.com/inward/record.url?scp=77957962700&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957962700&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3181eee4ff
DO - 10.1212/WNL.0b013e3181eee4ff
M3 - Editorial
C2 - 20720190
AN - SCOPUS:77957962700
SN - 0028-3878
VL - 75
SP - 680
EP - 681
JO - Neurology
JF - Neurology
IS - 8